Literature DB >> 36258854

A xenograft study of human adipose stromal cell-based vocal fold mucosal replacement in rabbits.

Eric K Tran1, Yazeed Alhiyari1, Kevin Juarez1,2, Bhavani Shankara Gowda1,3, Feng Schrader1,3, Dipti P Sajed4, Jennifer L Long1,3.   

Abstract

Objectives: Vocal fold (VF) scarring, manifested by increased collagen, decreased glycosaminoglycans (GAGs), and disrupted elastic fibers, remains a negative consequence of VF injury or resection. The objective of this study is to compare four reconstructive options after Vf mucosal resection in rabbits. A Cell-Based Outer Vocal fold Replacement (COVR) using human adipose-derived mesenchymal stromal cells (hASCs) in fibrin scaffold is directly compared with a decellularized scaffold implant, hASC injection, and resection alone without reconstruction. The primary hypothesis is that the cells-in-scaffold construct better reconstitutes the VF structure than either cells or scaffold alone, or than healing by secondary intention.
Methods: A total of49 rabbits received bilateral VF cordectomy, followed by either COVR implant, decellularized scaffold implant, hASC injection, or no reconstruction (injured control group). Larynges were harvested after 6 weeks.
Results: Histology demonstrated greater lamina propria thickness, less collagen deposition, and more GAGs in COVR animals versus all other treatment groups. Evidence of persistent human cells was found in about half of the cell-treated animals. RNA levels of fibrosis pathway and macrophage phenotype markers were statistically unchanged among treatment groups at 6 weeks.
Conclusion: These data support the efficacy of COVR implantation in restoring VF microstructure in rabbits. The intact COVR was required; isolated components of decellularized scaffold or injected hASC still produced histologic scarring. We propose that the unique bilayered cell structure within fibrin enables controlled matrix remodeling to minimize wound contraction and fibrosis, and to promote GAG deposition. Level of Evidence: Basic science study.
© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.

Entities:  

Keywords:  adipose‐derived stromal cells; decellularized scaffold; extracellular matrix; fibrin; regenerative medicine; vocal fold

Year:  2022        PMID: 36258854      PMCID: PMC9575091          DOI: 10.1002/lio2.929

Source DB:  PubMed          Journal:  Laryngoscope Investig Otolaryngol        ISSN: 2378-8038


  22 in total

1.  Repairing the vibratory vocal fold.

Authors:  Jennifer L Long
Journal:  Laryngoscope       Date:  2017-08-03       Impact factor: 3.325

2.  Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering.

Authors:  Jennifer L Long; Patricia Zuk; Gerald S Berke; Dinesh K Chhetri
Journal:  Laryngoscope       Date:  2010-01       Impact factor: 3.325

3.  Glottic regeneration with a tissue-engineering technique, using acellular extracellular matrix scaffold in a canine model.

Authors:  Morimasa Kitamura; Shigeru Hirano; Shin-Ichi Kanemaru; Yoshiharu Kitani; Satoshi Ohno; Tsuyoshi Kojima; Tatsuo Nakamura; Juichi Ito; Clark A Rosen; Thomas W Gilbert
Journal:  J Tissue Eng Regen Med       Date:  2014-01-08       Impact factor: 3.963

4.  Mesenchymal stromal cells modulate tissue repair responses within the injured vocal fold.

Authors:  Srinivasa Rao Nagubothu; Rachael V Sugars; Nikolce Tudzarovski; Anton Törnqvist Andrén; Matteo Bottai; Lindsay C Davies; Stellan Hertegård; Katarina Le Blanc
Journal:  Laryngoscope       Date:  2019-03-05       Impact factor: 3.325

5.  Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection.

Authors:  S Hertegård; J Cedervall; B Svensson; K Forsberg; F H J Maurer; D Vidovska; P Olivius; L Ahrlund-Richter; K Le Blanc
Journal:  Laryngoscope       Date:  2006-07       Impact factor: 3.325

6.  Feasibility of First Injection of Autologous Adipose Tissue-Derived Stromal Vascular Fraction in Human Scarred Vocal Folds: A Nonrandomized Controlled Trial.

Authors:  Alexia Mattei; Baptiste Bertrand; Elisabeth Jouve; Théo Blaise; Cécile Philandrianos; Fanny Grimaud; Laurent Giraudo; Houssein Aboudou; Chloé Dumoulin; Laurent Arnaud; Joana Revis; Camille Galant; Mélanie Velier; Julie Veran; Françoise Dignat-George; Patrick Dessi; Florence Sabatier; Jérémy Magalon; Antoine Giovanni
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-04-01       Impact factor: 6.223

7.  NR4A1 is an endogenous inhibitor of vocal fold fibrosis.

Authors:  Nao Hiwatashi; Renjie Bing; Iv Kraja; Ryan C Branski
Journal:  Laryngoscope       Date:  2017-06-05       Impact factor: 3.325

8.  SMAD3 expression and regulation of fibroplasia in vocal fold injury.

Authors:  Nao Hiwatashi; Peter A Benedict; Gregory R Dion; Renjie Bing; Iv Kraja; Milan R Amin; Ryan C Branski
Journal:  Laryngoscope       Date:  2017-05-20       Impact factor: 3.325

9.  Bone marrow-derived clonal mesenchymal stem cells as a source of cell therapy for promoting vocal fold wound healing.

Authors:  Young-Mo Kim; Tacghee Yi; Jeong-Seok Choi; Songyi Lee; Yun Ho Jang; Chul-Ho Kim; Sun U Song; Jae-Yol Lim
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-02       Impact factor: 1.547

10.  In vivo vocal fold cover layer replacement.

Authors:  Jennifer Long; Jonathan Salinas; Sassan Rafizadeh; Georg Luegmair; Zhaoyan Zhang; Dinesh Chhetri
Journal:  Laryngoscope       Date:  2014-09-12       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.